Anoxic-Ischemic Encephalopathy clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 18 years and up
RESTORE is a randomized clinical trial investigating the safety and feasibility of using EEG treatment targets (burst suppression vs. seizure suppression) for post-cardiac arrest refractory status epilepticus treatment.
San Francisco, California